Abstract
Understanding the host factors critical for Kaposi’s sarcoma-associated
herpesvirus (KSHV) lytic replication can identify new targets for
therapeutic intervention. Using pharmacological and genetic silencing
approaches, we reveal for the first time that KSHV requires a B cell
expressed voltage-gated K+ channel, Kv1.3, to enhance lytic replication. We show that the KSHV replication and transcription activator (RTA) protein upregulates Kv1.3 expression, leading to enhanced K+ channel activity and hyperpolarisation of the B cell membrane. Enhanced Kv1.3 activity then promotes intracellular Ca2+ influx through Cav3.2, a T-type Ca2+ channel, leading to the Ca2+
driven nuclear localisation of NFAT and the subsequent NFAT1-responsive
gene expression. Importantly, KSHV lytic replication and infectious
virion production could be inhibited by both Kv1.3 and Cav3.2 blockers or through Kv1.3
silencing. These findings provide new mechanistic insight into the
essential role of host ion channels during KSHV infection and highlight Kv1.3 and Cav3.2 as new druggable host factors that are key to the successful completion of KSHV lytic replication.
| Original language | English |
|---|---|
| Publisher | bioRxiv |
| Number of pages | 27 |
| DOIs | |
| Publication status | Published - 10 Sept 2021 |
Keywords
- Kaposi's sarcoma (KS)-associated herpesvirus
- Antiviral
- Ion channel
- Kv1.3
- Cav3.2
- NFAT
- Lytic replication